RUGGIERI, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 3.268
EU - Europa 1.436
AS - Asia 905
SA - Sud America 175
AF - Africa 15
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.803
Nazione #
US - Stati Uniti d'America 3.240
GB - Regno Unito 610
CN - Cina 329
SG - Singapore 271
DE - Germania 176
IT - Italia 162
BR - Brasile 148
SE - Svezia 145
HK - Hong Kong 127
RU - Federazione Russa 70
UA - Ucraina 56
FR - Francia 51
FI - Finlandia 45
KR - Corea 40
VN - Vietnam 39
IE - Irlanda 31
TR - Turchia 29
BG - Bulgaria 23
BE - Belgio 17
IN - India 16
CA - Canada 14
ID - Indonesia 12
AR - Argentina 10
MX - Messico 9
ES - Italia 8
NL - Olanda 8
MY - Malesia 7
EC - Ecuador 6
IR - Iran 6
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
BD - Bangladesh 4
CO - Colombia 4
LT - Lituania 4
PL - Polonia 4
UZ - Uzbekistan 4
AT - Austria 3
GR - Grecia 3
NO - Norvegia 3
RO - Romania 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IQ - Iraq 2
JP - Giappone 2
LY - Libia 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AU - Australia 1
AZ - Azerbaigian 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 5.803
Città #
Southend 478
Fairfield 387
Ashburn 312
Santa Clara 262
Woodbridge 229
Chandler 183
Singapore 165
Houston 155
Seattle 142
Hong Kong 126
Wilmington 122
Dearborn 121
Jacksonville 110
Cambridge 109
Ann Arbor 104
Hefei 102
Chicago 97
Nyköping 80
London 65
Los Angeles 64
Beijing 60
Modena 41
New York 38
Salt Lake City 37
San Diego 37
Dublin 31
Moscow 26
Helsinki 25
Princeton 25
Sofia 23
Council Bluffs 22
Seoul 22
Eugene 21
Bremen 20
Fremont 20
Elk Grove Village 17
Munich 17
Izmir 16
Brussels 15
Seongnam 15
Frankfurt am Main 14
Boardman 12
Columbus 12
Lancaster 12
Buffalo 11
São Paulo 11
Des Moines 10
Ho Chi Minh City 10
Jakarta 10
Norwalk 10
Phoenix 10
Tampa 10
The Dalles 10
Sterling 9
Milan 8
Redwood City 8
Shanghai 8
Bologna 7
Falls Church 7
Grafing 7
Prescot 7
Toronto 7
Brooklyn 6
Dong Ket 6
Dulles 6
Nanjing 6
Orem 6
Redondo Beach 6
Dallas 5
Detroit 5
Hanoi 5
Kilburn 5
Nuremberg 5
Paris 5
Rome 5
Tabriz 5
Ankara 4
Curitiba 4
Ferrara 4
Johannesburg 4
Kansas City 4
Maintal 4
Mexico City 4
Miami 4
Newark 4
Piacenza 4
Pittsburgh 4
Poplar 4
Rio de Janeiro 4
Amsterdam 3
Boston 3
Campinas 3
Changsha 3
Denver 3
Florence 3
Gif-sur-Yvette 3
Guangzhou 3
Nanchang 3
New Delhi 3
Oslo 3
Totale 4.312
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 416
ANXIOLYTIC LIKE EFFECT OF NEUROPEPTIDE S IN THE RAT DEFENSIVE BURYING. 366
Chronic treatment with the selective NOP receptor antagonist [Nphe1,Arg14,Lys15]N/OFQ-NH2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats 361
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 319
The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats 300
Neuropeptide S stimulates human monocyte chemotaxis via NPS receptor activation. 280
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 279
[tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies. 276
Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats 272
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 270
Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 265
Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating. 264
Differential involvement of opioidergic and serotoninergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol 258
Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. 257
Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system 248
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 239
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 221
In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505 219
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 218
Switching from HPLC/UV to MEIA for whole blood sirolimus quantitation: Comparison of methods 168
Glutamate-mediated astrocyte-to-neuron signaling in the rat dorsal horn 168
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 129
Respiratory muscle dysfunction and associated risk factors following COVID-19-2 related hospitalisation. 70
Totale 5.863
Categoria #
all - tutte 26.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 50 93 48 64 33 92 49 32
2021/2022524 27 30 82 29 11 21 31 31 69 42 104 47
2022/2023520 53 75 35 60 54 73 7 58 49 7 18 31
2023/2024273 7 11 24 32 56 19 21 36 6 7 27 27
2024/20251.028 36 9 11 71 182 141 89 61 118 56 117 137
2025/20261.103 207 85 150 431 230 0 0 0 0 0 0 0
Totale 5.863